دورية أكاديمية

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.

التفاصيل البيبلوغرافية
العنوان: Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.
المؤلفون: Lipson, D. A. inc., Halpin, David M
بيانات النشر: NEJM
سنة النشر: 2018
المجموعة: RD&E Research Repository (Royal Devon and Exeter NHS Foundation Trust)
مصطلحات موضوعية: Wessex Classification Subject Headings::Respiratory medicine, Administration, Inhalation, Adrenergic beta-Agonists, Adult, Aged, Androstadienes, Benzyl Alcohols, Bronchodilator Agents, Chlorobenzenes, Double-Blind Method, Drug Administration Schedule, Drug Combinations, Dyspnea, Female, Glucocorticoids, Hospitalization, Humans, Intention to Treat Analysis, Male, Middle Aged, Muscarinic Antagonists, Pulmonary Disease, Chronic Obstructive, Quality of Life, Quinuclidines
الوصف: The benefits of triple therapy for chronic obstructive pulmonary disease (COPD) with an inhaled glucocorticoid, a long-acting muscarinic antagonist (LAMA), and a long-acting β2-agonist (LABA), as compared with dual therapy (either inhaled glucocorticoid-LABA or LAMA-LABA), are uncertain.
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 1533-4406
29668352
العلاقة: Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. 2018, 378 (18):1671-1680 N. Engl. J. Med.; http://hdl.handle.net/11287/620707Test; The New England journal of medicine
DOI: 10.1056/NEJMoa1713901
الإتاحة: https://doi.org/10.1056/NEJMoa1713901Test
http://hdl.handle.net/11287/620707Test
حقوق: Archived with thanks to The New England journal of medicine
رقم الانضمام: edsbas.985A9F66
قاعدة البيانات: BASE
ResultId 1
Header edsbas
BASE
edsbas.985A9F66
821
3
Academic Journal
academicJournal
821.334289550781
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.985A9F66&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Array ( [0] => Array ( [Url] => https://doi.org/10.1056/NEJMoa1713901# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Lipson%2C+D%2E+A%2E+inc%2E%22">Lipson, D. A. inc.</searchLink><br /><searchLink fieldCode="AR" term="%22Halpin%2C+David+M%22">Halpin, David M</searchLink> )
Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => NEJM )
Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2018 )
Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => RD&E Research Repository (Royal Devon and Exeter NHS Foundation Trust) )
Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Wessex+Classification+Subject+Headings%3A%3ARespiratory+medicine%22">Wessex Classification Subject Headings::Respiratory medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Administration%22">Administration</searchLink><br /><searchLink fieldCode="DE" term="%22Inhalation%22">Inhalation</searchLink><br /><searchLink fieldCode="DE" term="%22Adrenergic+beta-Agonists%22">Adrenergic beta-Agonists</searchLink><br /><searchLink fieldCode="DE" term="%22Adult%22">Adult</searchLink><br /><searchLink fieldCode="DE" term="%22Aged%22">Aged</searchLink><br /><searchLink fieldCode="DE" term="%22Androstadienes%22">Androstadienes</searchLink><br /><searchLink fieldCode="DE" term="%22Benzyl+Alcohols%22">Benzyl Alcohols</searchLink><br /><searchLink fieldCode="DE" term="%22Bronchodilator+Agents%22">Bronchodilator Agents</searchLink><br /><searchLink fieldCode="DE" term="%22Chlorobenzenes%22">Chlorobenzenes</searchLink><br /><searchLink fieldCode="DE" term="%22Double-Blind+Method%22">Double-Blind Method</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+Administration+Schedule%22">Drug Administration Schedule</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+Combinations%22">Drug Combinations</searchLink><br /><searchLink fieldCode="DE" term="%22Dyspnea%22">Dyspnea</searchLink><br /><searchLink fieldCode="DE" term="%22Female%22">Female</searchLink><br /><searchLink fieldCode="DE" term="%22Glucocorticoids%22">Glucocorticoids</searchLink><br /><searchLink fieldCode="DE" term="%22Hospitalization%22">Hospitalization</searchLink><br /><searchLink fieldCode="DE" term="%22Humans%22">Humans</searchLink><br /><searchLink fieldCode="DE" term="%22Intention+to+Treat+Analysis%22">Intention to Treat Analysis</searchLink><br /><searchLink fieldCode="DE" term="%22Male%22">Male</searchLink><br /><searchLink fieldCode="DE" term="%22Middle+Aged%22">Middle Aged</searchLink><br /><searchLink fieldCode="DE" term="%22Muscarinic+Antagonists%22">Muscarinic Antagonists</searchLink><br /><searchLink fieldCode="DE" term="%22Pulmonary+Disease%22">Pulmonary Disease</searchLink><br /><searchLink fieldCode="DE" term="%22Chronic+Obstructive%22">Chronic Obstructive</searchLink><br /><searchLink fieldCode="DE" term="%22Quality+of+Life%22">Quality of Life</searchLink><br /><searchLink fieldCode="DE" term="%22Quinuclidines%22">Quinuclidines</searchLink> )
Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => The benefits of triple therapy for chronic obstructive pulmonary disease (COPD) with an inhaled glucocorticoid, a long-acting muscarinic antagonist (LAMA), and a long-acting β2-agonist (LABA), as compared with dual therapy (either inhaled glucocorticoid-LABA or LAMA-LABA), are uncertain. )
Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper )
Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English )
Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 1533-4406<br />29668352 )
Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. 2018, 378 (18):1671-1680 N. Engl. J. Med.; http://hdl.handle.net/11287/620707; The New England journal of medicine )
Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1056/NEJMoa1713901 )
Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://doi.org/10.1056/NEJMoa1713901<br />http://hdl.handle.net/11287/620707 )
Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => Archived with thanks to The New England journal of medicine )
Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.985A9F66 )
RecordInfo Array ( [BibEntity] => Array ( [Identifiers] => Array ( [0] => Array ( [Type] => doi [Value] => 10.1056/NEJMoa1713901 ) ) [Languages] => Array ( [0] => Array ( [Text] => English ) ) [Subjects] => Array ( [0] => Array ( [SubjectFull] => Wessex Classification Subject Headings::Respiratory medicine [Type] => general ) [1] => Array ( [SubjectFull] => Administration [Type] => general ) [2] => Array ( [SubjectFull] => Inhalation [Type] => general ) [3] => Array ( [SubjectFull] => Adrenergic beta-Agonists [Type] => general ) [4] => Array ( [SubjectFull] => Adult [Type] => general ) [5] => Array ( [SubjectFull] => Aged [Type] => general ) [6] => Array ( [SubjectFull] => Androstadienes [Type] => general ) [7] => Array ( [SubjectFull] => Benzyl Alcohols [Type] => general ) [8] => Array ( [SubjectFull] => Bronchodilator Agents [Type] => general ) [9] => Array ( [SubjectFull] => Chlorobenzenes [Type] => general ) [10] => Array ( [SubjectFull] => Double-Blind Method [Type] => general ) [11] => Array ( [SubjectFull] => Drug Administration Schedule [Type] => general ) [12] => Array ( [SubjectFull] => Drug Combinations [Type] => general ) [13] => Array ( [SubjectFull] => Dyspnea [Type] => general ) [14] => Array ( [SubjectFull] => Female [Type] => general ) [15] => Array ( [SubjectFull] => Glucocorticoids [Type] => general ) [16] => Array ( [SubjectFull] => Hospitalization [Type] => general ) [17] => Array ( [SubjectFull] => Humans [Type] => general ) [18] => Array ( [SubjectFull] => Intention to Treat Analysis [Type] => general ) [19] => Array ( [SubjectFull] => Male [Type] => general ) [20] => Array ( [SubjectFull] => Middle Aged [Type] => general ) [21] => Array ( [SubjectFull] => Muscarinic Antagonists [Type] => general ) [22] => Array ( [SubjectFull] => Pulmonary Disease [Type] => general ) [23] => Array ( [SubjectFull] => Chronic Obstructive [Type] => general ) [24] => Array ( [SubjectFull] => Quality of Life [Type] => general ) [25] => Array ( [SubjectFull] => Quinuclidines [Type] => general ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Lipson, D. A. inc. ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Halpin, David M ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 01 [M] => 01 [Type] => published [Y] => 2018 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-print [Value] => 15334406 ) [1] => Array ( [Type] => issn-print [Value] => 29668352 ) [2] => Array ( [Type] => issn-locals [Value] => edsbas ) ) ) ) ) ) )
IllustrationInfo